• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学生物标志物在膀胱病理学中的适用性和实用性。

The applicability and utility of immunohistochemical biomarkers in bladder pathology.

机构信息

Departments of Pathology Indiana University, Indianapolis, IN, 46202, USA.

Department of Pathology, Case Western Reserve University, Cleveland, OH, 44106, USA.

出版信息

Hum Pathol. 2020 Apr;98:32-55. doi: 10.1016/j.humpath.2020.01.004. Epub 2020 Feb 6.

DOI:10.1016/j.humpath.2020.01.004
PMID:32035992
Abstract

Urinary bladder specimens are frequently encountered in the daily practice of surgical pathologists. The spectrum of pathologic entities encountered in bladder specimens is extraordinarily broad, and in some instances, immunohistochemical stains are used to help characterize challenging bladder lesions. Cost-effective biomarker selection tailored to the differential diagnosis facilitates an accurate diagnosis. This comprehensive review is prepared as a reference guide for the use of immunohistochemistry to categorize primary and secondary bladder neoplasms and to evaluate metastatic cancers for possible bladder origin.

摘要

在外科病理学家的日常工作中,经常会遇到膀胱标本。在膀胱标本中遇到的病理实体的范围非常广泛,在某些情况下,免疫组织化学染色被用于帮助确定具有挑战性的膀胱病变。针对鉴别诊断选择具有成本效益的生物标志物有助于做出准确的诊断。本综述旨在作为使用免疫组织化学对原发性和继发性膀胱肿瘤进行分类以及评估可能源自膀胱的转移性癌症的参考指南。

相似文献

1
The applicability and utility of immunohistochemical biomarkers in bladder pathology.免疫组织化学生物标志物在膀胱病理学中的适用性和实用性。
Hum Pathol. 2020 Apr;98:32-55. doi: 10.1016/j.humpath.2020.01.004. Epub 2020 Feb 6.
2
Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.SATB2在鉴别膀胱/泌尿道腺性病变起源部位中的作用。
Hum Pathol. 2017 Sep;67:152-159. doi: 10.1016/j.humpath.2017.07.002. Epub 2017 Jul 13.
3
PD-L1 Antibody Comparison in Urothelial Carcinoma.尿路上皮癌中PD-L1抗体的比较
Eur Urol. 2019 Mar;75(3):538-540. doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27.
4
Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.浆细胞样尿路上皮癌与膀胱继发性癌累及的免疫组化鉴别
Am J Surg Pathol. 2017 Nov;41(11):1570-1575. doi: 10.1097/PAS.0000000000000922.
5
Significantly increased accuracy of urothelial carcinoma detection in destained urine slides with combined analysis of standard cytology and CK-20 immunostaing.通过标准细胞学和CK-20免疫染色联合分析,显著提高了脱色尿涂片检测尿路上皮癌的准确性。
Acta Cytol. 2009 May-Jun;53(3):357-60. doi: 10.1159/000325325.
6
Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.角蛋白 17 是尿路上皮肿瘤的一种敏感且特异的生物标志物。
Mod Pathol. 2019 May;32(5):717-724. doi: 10.1038/s41379-018-0177-5. Epub 2018 Nov 15.
7
Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.成人伴横纹肌样分化的膀胱尿路上皮肿瘤:临床、病理和免疫组织化学研究。
Diagn Pathol. 2011 Jul 15;6:66. doi: 10.1186/1746-1596-6-66.
8
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.
Hum Pathol. 2015 Jul;46(7):1040-4. doi: 10.1016/j.humpath.2015.03.004. Epub 2015 Mar 25.
9
Expression of uroplakin II and GATA-3 in bladder cancer mimickers: caveats in the use of a limited panel to determine cell of origin in bladder lesions.尿路上皮蛋白II和GATA-3在膀胱酷似癌中的表达:在使用有限的一组指标来确定膀胱病变起源细胞时的注意事项。
Hum Pathol. 2021 Jul;113:28-33. doi: 10.1016/j.humpath.2021.04.005. Epub 2021 Apr 19.
10
PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma.PD-L1 免疫组织化学检测在膀胱尿路上皮癌和下咽鳞状细胞癌中的一致性。
Am J Surg Pathol. 2018 Aug;42(8):1059-1066. doi: 10.1097/PAS.0000000000001084.

引用本文的文献

1
Diagnostic, Prognostic, and Predictive Tissue Biomarkers in Urothelial Carcinoma In Situ: A Narrative Review.原位尿路上皮癌的诊断、预后和预测性组织生物标志物:一项叙述性综述
Diagnostics (Basel). 2025 Aug 26;15(17):2163. doi: 10.3390/diagnostics15172163.
2
Brain metastasis in a patient with metastatic urothelial carcinoma after 7 years of avelumab maintenance therapy: A case report.阿维鲁单抗维持治疗7年后转移性尿路上皮癌患者发生脑转移:一例报告
Urol Case Rep. 2025 Jun 16;61:103109. doi: 10.1016/j.eucr.2025.103109. eCollection 2025 Jul.
3
Resveratrol Induces Oxidative Stress and Downregulates GPX4 and xCT to Activate the Ferroptosis Pathway for Anti-Bladder Cancer Organoids.
白藜芦醇诱导氧化应激并下调GPX4和xCT以激活铁死亡途径用于抗膀胱类器官。
J Cancer. 2025 Jun 9;16(8):2613-2625. doi: 10.7150/jca.109350. eCollection 2025.
4
AMIGO2 expression at the invasive front of bladder cancer predicts recurrence-free and overall survival after radical cystectomy.膀胱肿瘤侵袭前沿的AMIGO2表达可预测根治性膀胱切除术后的无复发生存率和总生存率。
Oncol Lett. 2025 May 13;30(1):339. doi: 10.3892/ol.2025.15085. eCollection 2025 Jul.
5
Recurrent bladder urothelial carcinoma complicated with primary bladder large cell neuroendocrine carcinoma: a case report and literature review.复发性膀胱尿路上皮癌合并原发性膀胱大细胞神经内分泌癌:1例报告并文献复习
Front Oncol. 2024 Aug 2;14:1369649. doi: 10.3389/fonc.2024.1369649. eCollection 2024.
6
Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes.膀胱巨大细胞癌:临床病理分析和肿瘤学结果。
Virchows Arch. 2024 Sep;485(3):535-546. doi: 10.1007/s00428-024-03858-w. Epub 2024 Jul 18.
7
Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors.膀胱癌分类的最新进展——来自世界卫生组织《泌尿系统及男性生殖器官肿瘤分类》第5版的更新
Bladder Cancer. 2023 Mar 31;9(1):1-14. doi: 10.3233/BLC-220106. eCollection 2023.
8
Inflammatory myofibroblastic tumor of the genitourinary tract: a narrative review.泌尿生殖道炎性肌纤维母细胞瘤:一篇叙述性综述
Transl Androl Urol. 2024 Feb 29;13(2):308-319. doi: 10.21037/tau-23-471. Epub 2024 Feb 22.
9
GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall.GATA3 在泌尿系统透明细胞腺癌中的表达:一个潜在的诊断陷阱。
Diagn Pathol. 2022 Nov 1;17(1):87. doi: 10.1186/s13000-022-01269-6.
10
[Diagnostic and predictive markers in urinary tract cytology].[尿路细胞学中的诊断和预测标志物]
Pathologe. 2022 Mar;43(2):99-104. doi: 10.1007/s00292-022-01053-9. Epub 2022 Feb 8.